格隆汇2月26日丨泰凌医药(01011.HK)公告，基于对集团截至2025年12月31日止年度(「本年度」)未经审 核综合管理账目之初步审阅及董事会目前可得资料，预期集团于本年度将录得公司拥有人应占亏损净额 介乎约人民币2500万元至人民币3000万元，较截至2024年12月31日止年度(「上一年度」)录得之公司拥 有人应占亏损净额约人民币5340万元，显着减少约43.8%至53.2%。预期亏损减少主要归因于以下因 素：(i)上一年度因会计重分类而确认之围绕北京康辰生物科技有限公司股权的一次性非现金公允价值亏 损约人民币2950万元，于本年度不再出现；及(ii)按公允值计入损益之金融资产(即上述股权)于本年度录 得约人民币1400万元的公允价值收益。 ...

Core Viewpoint - Huaxin Holdings (01657) expects to incur a loss of no more than approximately HKD 6 million for the six months ending October 31, 2025, which is an improvement compared to a loss of approximately HKD 9 million for the six months ending October 31, 2024 [1] Group 1 - The estimated reduction in loss is primarily due to an increase in revenue and gross profit from its supply of apparel products [1] - There has been an increase in the number of sales orders and revenue from supplying apparel products to a major client based in the UK [1] - The company has also seen a decrease in the provision for impairment losses recognized on trade receivables [1]

Core Viewpoint - The company expects a significant reduction in losses for the six months ending September 30, 2025, with estimated losses between HKD 45 million and HKD 75 million, compared to a loss of approximately HKD 176 million in the same period last year [1] Financial Performance - The anticipated reduction in losses is primarily attributed to a decrease in fair value losses on the group's investment properties [1]

Core Viewpoint - China Environment Resources (01130) expects a significant reduction in consolidated losses for the fiscal year ending June 30, 2025, by at least 35% compared to the loss of approximately HKD 72.1 million in 2024 [1] Financial Performance - The anticipated loss reduction is attributed to several factors, including a decrease in revenue from recycled metal due to lower demand, resulting in estimated revenue of approximately HKD 60.7 million and a gross profit of about HKD 13.3 million [1] - Other income, revenue, and losses are expected to decrease to around HKD 1.6 million [1] - Administrative and operational expenses are projected to decline to approximately HKD 35.7 million [1] Asset Valuation - Fair value losses on investment properties are expected to decrease to about HKD 15.7 million [1] - Losses from changes in the fair value of biological assets are anticipated to reduce to approximately HKD 5.4 million [1] - Net gains from fair value changes of investments measured at fair value through profit or loss are expected to increase to around HKD 5.7 million [1] Provisions and Costs - Provisions for receivables impairment losses are projected to increase to about HKD 3 million [1] - Financing costs are expected to decrease to approximately HKD 6 million [1] - Tax credits are anticipated to decrease to around HKD 2.3 million [1]